,,ii #aagth ,,congress #ast ,session ,s4 #aagf ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,april #ae1 #bjba,ms4 ,smith 7for herself and ,mr4 ,cassidy7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to establish a grant program to support the manufacture and stockpiling of essential generic antibiotic drugs4 #a4 ,short title ,this ,act may be cited as the ,onshoring ,essential ,antibiotics ,act4 #b4 ,essential generic antibiotic program 7a7 ,grant program 7#a7 ,establishment ,not later than #fj days after the date of enactment of this ,act1 the ,secretary shall establish a program to provide grants to manufacturers of essential generic antibiotic drugs1 or the active pharmaceutical ingredient or key starting material of an essential generic antibiotic drug1 to support activities described in paragraph 7#c74 7#b7 ,eligible entities ,the ,secretary shall award grants under this subsection to not more than #c manufacturers of an essential generic antibiotic drug4 ,each such recipient shall be a manufacturer that-- 7,a7 has implemented and maintains an effective quality management system1 under parts #baj and #baa of title #ba1 ,code of ,federal ,regulations 7or any successor regulations72 7,b7 has a strong record of compliance with the requirements of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq472 7,c7 uses complex pharmaceutical manufacturing to produce a finished drug product or active pharmaceutical ingredient pursuant to an application approved under section subsection 7c7 or 7j7 of section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee72 7,d7 commits to using advanced manufacturing in its manufacturing operations2 and 7,e7 has existing manufacturing facilities and operations in the ,united ,states4 7#c7 ,use of funds ,a recipient of a grant under this subsection may use such grant funds to-- 7,a7 with respect to manufacturing an essential generic antibiotic drug-- 7i7 expand1 upgrade1 or recommission an existing manufacturing facility located in the ,united ,states2 or 7ii7 construct a new manufacturing facility in the ,united ,states2 and 7,b7 manufacture essential generic antibiotic drugs4 7b7 ,use of funds ,to purchase essential generic antibiotic drugs for stockpiling ,the ,secretary may use amounts appropriated under this section to purchase1 store1 stockpile1 or disposition essential generic antibiotic drugs manufactured in the ,united ,states4 7c7 ,definitions ,for purposes of this section3 7#a7 ,active pharmaceutical ingredient ,the term active pharmaceutical ingredient has the meaning given such term in section #gdd;,a of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cgi;j-#da74 7#b7 ,essential generic antibiotic drug ,the term essential generic antibiotic drug means an antibacterial or antifungal drug approved by the ,food and ,drug ,administration under section #eje7;j7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7;j77 that the ,secretary determines to be medically necessary to have available at all times in an amount adequate to serve patient needs1 including beta-lactams 7including penicillin and cephalosporin derivatives7 and non-beta lactams 7including tetracycline and aminoglycoside derivatives74 7#c7 ,key starting material ,the term key starting material means any component of a drug that the ,secretary determines to be critical to the safety and effectiveness of the drug4 7#d7 ,secretary ,the term ,secretary means the ,secretary of ,health and ,human ,services4 7#e7 ,united ,states ,the term ,united ,states means the #ej ,states1 the ,district of ,columbia1 territories1 and ,tribal lands4 7d7 ,funding ,for purposes of carrying out this section1 there is appropriated1 out of amounts in the ,treasury not otherwise appropriated1 #ejj1jjj1jjj for fiscal year #bjba1 to remain available through ,september #cj1 #bjbc4 #c4 ,study and report 7a7 ,in general ,the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary7 shall enter into a contract with an entity under which such entity carries out a study on the manufacture of essential generic antibiotic drugs and issues a report that includes-- 7#a7 recommendations about which antibiotics the ,secretary should prioritize for purposes of the program under section #b1 based on factors that include necessity of use1 vulnerability to foreign supply chain disruptions1 and availability of alternatives2 and 7#b7 the expected effect of increased domestic manufacturing of drugs on drug costs to consumers4 7b7 ,authorization ,to carry out this section1 there is authorized to be appropriated #b1jjj1jjj for fiscal year #bjba1 to remain available until ,september #cj1 #bjbb4